Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811117 | 0.96 | MEN1 (0.51) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL738953 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL4312808 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL16005690 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL19173031 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL1801722 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL1632799 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL8928066 | 0.94 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL11024894 | 0.90 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL319842 | 0.88 | MEN1 (0.43) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447378-B | Cilobodoxin chirality Process for the preparation of intermediates | 斯坦德药典标准物质研发(湖北)有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-109336740-B | Preparation method of 4,4, 4-trifluoro-1-butanol | 湖南有色郴州氟化学有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-117157271-B | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2026-05-15 | — | — | CN | disclosed |
| US-20260070882-A1 | PHOTOSTABLE MIMICS OF MACULAR PIGMENT | JOHNSON & JOHNSON VISION CARE (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260062386-A1 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | JOHNSON & JOHNSON VISION CARE (US) | 2026-03-05 | — | — | US | disclosed |
| US-12509428-B2 | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-12497379-B2 | Photostable mimics of macular pigment | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| WO-2025079989-A1 | PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사유한양행 | 2025-04-17 | — | — | WO | disclosed |
| CN-117447378-B | Cilobodoxin chirality Process for the preparation of intermediates | 斯坦德药典标准物质研发(湖北)有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-115038685-B | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2024-12-13 | — | — | CN | disclosed |
| CN-119137093-A | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2024-12-13 | — | — | CN | disclosed |
| US-4696929-A | Derivative of piperazine having anti-allergic and anti-inflammatory action | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1987-09-29 | — | — | US | disclosed |
| WO-1987001706-A2 | C20 THROUGH C26 AMINO STEROIDS | THE UPJOHN COMPANY (US) | 1987-03-26 | — | — | WO | disclosed |
| EP-0188803-A1 | Piperazine derivative | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1986-07-30 | — | — | EP | disclosed |
| US-4413006-A | N-Aryl-N-phenoxy-alkyl-piperazine compounds useful in decreasing intracranial pressure | TANABE SEIYAKU CO., LTD. (JP) | 1983-11-01 | — | — | US | disclosed |
| EP-0034284-B1 | PIPERAZINE DERIVATIVE, PROCESSES FOR PREPARING THE SAME AND THERAPEUTIC COMPOSITIONS CONTAINING IT | Tanabe Seiyaku Co., Ltd. (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0034284-A2 | Piperazine derivative, processes for preparing the same and therapeutic compositions containing it | Tanabe Seiyaku Co., Ltd. (JP) | 1981-08-26 | — | — | EP | disclosed |
| US-4218375-A | SEDATIVES, ANTIHISTAMINES | ROUSSEL UCLAF (FR) | 1980-08-19 | — | — | US | disclosed |
| US-4154731-A | ANTISECRETORY AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1979-05-15 | — | — | US | disclosed |
| US-4105670-A | ANTISECRETORY, ANTIINFLAMMATORY, ANALGESIC, DECARBOXYLATION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062386-A1 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | ERCC1, MCM6, GPR6 | MEN1 3166/4885KMT2A 4362/4885KDM4C 2884/4885 |
| US-20260070882-A1 | PHOTOSTABLE MIMICS OF MACULAR PIGMENT | CRY1, CRY2, XPA | MEN1 458/4885KMT2A 3404/4885KDM4C 3491/4885 |
| US-12497379-B2 | Photostable mimics of macular pigment | CRY1, PDE6C, PDE6A | MEN1 50/4885KMT2A 2296/4885KDM4C 3223/4885 |
| US-12509428-B2 | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | ERCC1, OGG1, ERCC4 | MEN1 3553/4885KMT2A 3086/4885KDM4C 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.